Eosinophil Ribonucleases and Their Cutaneous Lesion-Forming Activity
Open Access
- 15 September 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 183 (6) , 4013-4020
Abstract
Eosinophil granule proteins are deposited in cutaneous lesions in many human diseases, but how these proteins contribute to pathophysiology is obscure. We injected eosinophil cationic protein (ECP or RNase 3), eosinophil-derived neurotoxin (EDN or RNase 2), eosinophil peroxidase (EPO), and major basic protein-1 (MBP1) intradermally into guinea pig and rabbit skin. ECP and EDN each induced distinct skin lesions at ≥2.5 μM that began at 2 days, peaking at ∼7 days and persisting up to 6 wk. These lesions were ulcerated (ECP) or crusted (EDN) with marked cellular infiltration. EPO and MBP1 (10 μM) each produced perceptible induration and erythema with moderate cellular infiltration resolving within 2 wk. ECP and EDN localized to dermal cells within 2 days, whereas EPO and MBP1 remained extracellular. Overall, cellular localization and RNase activity of ECP and EDN were critical for lesion formation; differential glycosylation, net cationic charge, or RNase activity alone did not account for lesion formation. Ulcerated lesions from patients with the hypereosinophilic syndrome showed ECP and EDN deposition comparable to that in guinea pig skin. In conclusion, ECP and EDN disrupt skin integrity and cause inflammation. Their presence in ulcerative skin lesions may explain certain findings in human eosinophil-associated diseases.Keywords
This publication has 49 references indexed in Scilit:
- Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2–MyD88 signal pathway in dendritic cells and enhances Th2 immune responsesJournal of Experimental Medicine, 2008
- A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic proteinJournal of Leukocyte Biology, 2007
- Lack of Eosinophil Peroxidase or Major Basic Protein Impairs Defense against Murine Filarial InfectionInfection and Immunity, 2006
- Interactions of eosinophil granule proteins with skinJournal of Allergy and Clinical Immunology, 2003
- Treatment of hypereosinophilic syndrome with imatinib mesilateThe Lancet, 2002
- The relationship between eosinophils, OKT6-positive cells and house dust mite (HDM) antigens in naturally occurring lesions of atopic dermatitisJournal of Dermatological Science, 1992
- MECHANISM OF MEMBRANE DAMAGE MEDIATED BY EOSINOPHIL MAJOR BASIC PROTEINThe Lancet, 1987
- Dermal Deposition of Eosinophil-Granule Major Basic Protein in Atopic DermatitisNew England Journal of Medicine, 1985
- Episodic Angioedema Associated with EosinophiliaNew England Journal of Medicine, 1984
- Continuous‐ and Semicontinuous‐Flow Blood Centrifugation Systems: Therapeutic Applications, with Plasma‐, Platelet‐, Lympha‐, and EosinapheresisTransfusion, 1977